BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8772037)

  • 21. Allergic dermatitis due to oral ebrotidine.
    Carretero Aníbarro P; Blanco Carmona J; García González F; Garcés Sotillos M; Herrero Gil D; Pérez Giménez R; Juste Picón S
    J Investig Allergol Clin Immunol; 1999; 9(3):193-4. PubMed ID: 10412683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
    Merki HS; Bender W; Labs R
    J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute generalized exanthematous pustulosis induced by ranitidine hydrochloride.
    Blanes Martínez M; Silvestre Salvador JF; Vergara Aguilera G; Betlloch Mas I; Pascual Ramírez JC
    Contact Dermatitis; 2003 Jul; 49(1):47. PubMed ID: 14641127
    [No Abstract]   [Full Text] [Related]  

  • 24. Cutaneous delayed reaction to ranitidine.
    Gonzalo-Garijo MA; Revenga-Arranz F; Rovira-Farré I
    Allergy; 1996 Sep; 51(9):659-60. PubMed ID: 8899121
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ranitidine and a rare adverse reaction: urticaria].
    Sancho Calabuig A; Palop Larrea V; López González E; Martínez-Mir I
    Aten Primaria; 1997 Oct; 20(7):396-7. PubMed ID: 9432226
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possibly ranitidine-induced autoimmune hepatitis].
    Luparini RL; Rotundo A; Mattace R; Marigliano V
    Ann Ital Med Int; 2000; 15(3):214-7. PubMed ID: 11059062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Which drug for peptic ulcer?].
    Hameeteman W; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of acid and gastric carcinoids.
    Elder JB
    Gut; 1985 Dec; 26(12):1279-83. PubMed ID: 2867953
    [No Abstract]   [Full Text] [Related]  

  • 29. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized exanthematous pustulosis induced by medications.
    Sawhney RA; Dubin DB; Otley CC; Kwan TH; Bowers KE
    Int J Dermatol; 1996 Nov; 35(11):826-7. PubMed ID: 8915744
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
    Andersen M; Schou JS
    Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of cisapride in gastric ulcer. Results of a double-blind randomized trial versus ranitidine and versus cisapride plus ranitidine.
    Testoni PA; Bagnolo F; Buizza M; Masci E; Toti GL; Spinelli A; Manzi G
    J Clin Gastroenterol; 1993 Jul; 17(1):5-9. PubMed ID: 8409300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety profile of H2-receptor antagonists: current status of famotidine.
    Levine JB
    J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
    Tomasko MA; Luskin AT
    Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative pharmacology of histamine H2-receptor antagonists.
    Sewing KF; Beil W; Hannemann H
    Drugs; 1988; 35 Suppl 3():25-9. PubMed ID: 2905246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical studies on the use of roxatidine acetate for the treatment of peptic ulcer in Japan.
    Inoue M
    Drugs; 1988; 35 Suppl 3():114-9. PubMed ID: 2905239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatic and hematological toxicities of therapy with H2-receptor antagonists].
    Hirota M; Matsushita M; Kiyota K; Shiroeda O; Inokuchi H; Onishi R; Kawai K
    Nihon Shokakibyo Gakkai Zasshi; 1993 Sep; 90(9):2132-6. PubMed ID: 8105121
    [No Abstract]   [Full Text] [Related]  

  • 39. Roxatidine acetate as maintenance treatment for patients with peptic ulcer disease. The European Cooperative Roxatidine Study Group.
    Clin Ther; 1991; 13(1):47-57. PubMed ID: 1674231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.